[1]
|
代丹, 洪达, 时艳艳, 等. SFTPC突变致儿童间质性肺病伴家系外显不全3例并文献复习[J]. 中国循证儿科杂志, 2017, 12(6): 446-451.
|
[2]
|
Gupta, A., et al. (2017) Genetic Disorders of Surfactant Protein Dysfunction: When to Consider and How to Investigate. Archives of Disease in Childhood, 102, 84-90. https://doi.org/10.1136/archdischild-2012-303143
|
[3]
|
申昆玲, 姚瑶. 关注儿童呼吸系统单基因病[J]. 中华实用儿科临床杂志, 2018, 33(4): 247-249.
|
[4]
|
Lucas, J.S., Davis, S.D., Omran, H., et al. (2020) Primary Ciliary Dyskinesia in the Genomics Age. The Lancet Respiratory Medicine, 8, 202-216. https://doi.org/10.1016/S2213-2600(19)30374-1
|
[5]
|
Boon, M., Smits, A., Cuppens, H., et al. (2014) Primary Ciliary Dyskinesia: Critical Evaluation of Clinical Symptoms and Diagnosis in Patients with Normal and Abnormal Ultrastructure. Orphanet Journal of Rare Diseases, 9, Article No. 11. https://doi.org/10.1186/1750-1172-9-11
|
[6]
|
Damseh, N., Quercia, N., Rumman, N., et al. (2017) Primary Ciliary Dyskinesia: Mechanisms and Management. The Application of Clinical Genetics, 10, 67-74. https://doi.org/10.2147/TACG.S127129
|
[7]
|
Guo, Z., Chen, W., Huang, J., et al. (2019) Clinical and Genetic Analysis of Patients with Primary Ciliary Dyskinesia Caused by Novel DNAAF3 Mutations. Journal of Human Genetics, 64, 711-719.
https://doi.org/10.1038/s10038-019-0609-1
|
[8]
|
Davis, S.D., Margaret, R., HyeSeung, L., et al. (2018) Primary Ciliary Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype. American Journal of Respiratory and Critical Care Medicine, 199, 190-198.
|
[9]
|
Polineni, D., Davis, S.D. and Dell, S.D. (2016) Treatment Recommendations in Primary Ciliary Dyskinesia. Paediatric Respiratory Reviews, 18, 39-45. https://doi.org/10.1016/j.prrv.2015.10.002
|
[10]
|
Bell, S.C., Mall, M.A., Gutierrez, H., et al. (2020) The Future of Cystic Fibrosis Care: A Global Perspective. The Lancet Respiratory Medicine, 8, 65-124. https://doi.org/10.1016/S2213-2600(19)30337-6
|
[11]
|
Harrison, M.J., Murphy, D.M., Plant, B.J., et al. (2013) Ivacaftor in a G551D Homozygote with Cystic Fibrosis. New England Journal of Medicine, 369, 1280-1282. https://doi.org/10.1056/NEJMc1213681
|
[12]
|
Turcu, S., Ashton, E., Jenkins, L., et al. (2013) Genetic Testing in Children with Surfactant Dysfunction. Archives of Disease in Childhood, 98, 490-495. https://doi.org/10.1136/archdischild-2012-303166
|
[13]
|
Nathan, N., Berdah, L., Delestrain, C., et al. (2020) Interstitial Lung Diseases in Children. La Presse médicale, 49, Article ID: 103909. https://doi.org/10.1016/j.lpm.2019.06.007
|
[14]
|
Borie, R., Danel, C., Debray, M.P., et al. (2011) Pulmonary Alveolar Proteinosis. The European Respiratory Review, 20, 98-107. https://doi.org/10.1183/09059180.00001311
|
[15]
|
Carolin, K., Reu, S., Teusch, V., et al. (2015) Genotype Alone Does Not Predict the Clinical Course of SFTPC Deficiency in Paediatric Patients. European Respiratory Journal, 46, 197-206. https://doi.org/10.1183/09031936.00129414
|
[16]
|
Athena, K., Hanny, A.S. and Kuter, D.J. (2018) Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management from the Hematologist’s Perspective. Haematologica, 103, 1433-1443. https://doi.org/10.3324/haematol.2018.193003
|
[17]
|
刘金荣, 刘辉, 王蓓, 等. 遗传性出血性毛细血管扩张症二例并文献复习[J]. 中华儿科杂志, 2020, 58(8): 674-678.
|
[18]
|
黄艳, 刘沉涛, 郑湘榕. 遗传性出血性毛细血管扩张症2例报道[J]. 中国当代儿科杂志, 2020, 22(9): 1041-1042.
|
[19]
|
Robert, F., Desroches-Castan, A., Bailly, S., et al. (2020) Future Treatments for Hereditary Hemorrhagic Telangiectasia. Orphanet Journal of Rare Diseases, 15, Article No. 4. https://doi.org/10.1186/s13023-019-1281-4
|
[20]
|
Mcdonald, J., Bayrak-Toydemir, P. and Pyeritz, R.E. (2011) Hereditary Hemorrhagic Telangiectasia: An Overview of Diagnosis, Management, and Pathogenesis. Genetics in Medicine, 13, 607-616.
https://doi.org/10.1097/GIM.0b013e3182136d32
|
[21]
|
胡婷, 朱红梅, 张竹, 等. 染色体微阵列分析在诊断核型分析未见异常的智力低下/发育迟滞患儿中的应用[J]. 中华医学遗传学杂志, 2017, 34(2): 169-172.
|
[22]
|
Horani, A., Ferkol, T.W., Dutcher, S.K., et al. (2016) Genetics and Biology of Primary Ciliary Dyskinesia. Paediatric Respiratory Reviews, 18, 18-24. https://doi.org/10.1016/j.prrv.2015.09.001
|
[23]
|
Kurland, G., Deterding, R.R., Hagood, J.S., et al. (2013) An Official American Thoracic Society Clinical Practice Guideline: Classification, Evaluation, and Management of Childhood Interstitial Lung Disease in Infancy. American Journal of Respiratory and Critical Care Medicine, 188, 376-394. https://doi.org/10.1164/rccm.201305-0923ST
|
[24]
|
王秋菊, 沈亦平, 邬玲仟, 等. 遗传变异分类标准与指南[J]. 中国科学, 2017, 47(6): 668-688.
|
[25]
|
Paff, T., Kooi, I.E., Moutaouakil, Y., et al. (2018) Diagnostic Yield of a Targeted Gene Panel in Primary Ciliary Dyskinesia Patients. Human Mutation, 39, 653-665. https://doi.org/10.1002/humu.23403
|
[26]
|
Waldrop, M.A. and Kolb, S.J. (2019) Current Treatment Options in Neurology-SMA Therapeutics. Current Treatment Options in Neurology, 21, 25. https://doi.org/10.1007/s11940-019-0568-z
|
[27]
|
Leigh, F., Ferlini, A., Biggar, D., et al. (2018) Neurology Care, Diagnostics, and Emerging Therapies of the Patient with Duchenne Muscular Dystrophy. Pediatrics, 142, S5-S16. https://doi.org/10.1542/peds.2018-0333C
|
[28]
|
Lai, M., Pifferi, M., Bush, A., et al. (2016) Gene Editing of DNAH11 Restores Normal Cilia Motility in Primary Ciliary Dyskinesia. Journal of Medical Genetics, 53, 242-249. https://doi.org/10.1136/jmedgenet-2015-103539
|